EAO 2025 - Paradigm shift in GBR and therapy of peri-implant and periodontal infections скачать в хорошем качестве

EAO 2025 - Paradigm shift in GBR and therapy of peri-implant and periodontal infections

The Regedent Symposium explores the paradigm shift in the treatment of periodontal and peri-implant diseases, as well as innovations in guided bone regeneration (GBR). Prof. Stefan Fickl presents the latest insights into the role of cross-linked hyaluronic acid gel in GBR procedures, after the introduction and review of the pre-clinical evidence about this material by Prof Anton Sculean. He addresses common clinical challenges and share compelling scientific evidence supporting the use of cross-linked hyaluronic acid, along with key learnings from his own clinical experience. Shifting focus to peri-implant diseases, Prof. Peter Windisch highlights the complexities of treating peri-implant mucositis and peri-implantitis. He discusses new strategies for managing these conditions non-surgically and with minimally invasive protocols, supported by recent clinical data. Dr. Egle Ramanauskaite introduces the novel CLEAN & SEAL therapy for the treatment of severe periodontitis, showcasing robust scientific evidence and real-world clinical outcomes. Together, these presentations illustrate how innovative regenerative biomaterials, such as cross-linked hyaluronic acid and buffered hypochlorite sodium, and biologically driven treatment protocols are changing the therapeutic landscape—offering predictable, patient-friendly alternatives to conventional surgical approaches. The symposium provides valuable guidance for clinicians seeking to adopt evidence-based, modern protocols in regenerative and infection management therapies.#eao